Latest Episode

David Bahnsen: Gilead, Prioritize Business Performance

At Gilead Sciences' 2026 annual meeting, the company faced a shareholder proposal from David Bahnsen, founder of The Bahnsen Group over the use of ESG and DEI metrics in executive compensation. Listen to David's presentation, urging the company to prioritize executive clarity and business performance over activist incentives.

"Gilead does not need to be grabbing headlines or seeking activist plaudits over inclusion initiatives. Its core business, meeting the needs of humanity by combatting the world’s deadliest diseases, is a noble, commendable, and lifesaving model that every investor can and ought to be proud of. Gilead has done it so very well."

Learn more about The Bahnsen Group at thebahnsengroup.com.

See omnystudio.com/listener for privacy information.